Warning about unproven stem cell treatments for COVID-19The Centre for Stem Cell Systems join the International Society for Stem Cell Research (ISSCR) and International Society for Cell & Gene Therapy (ISCT) in raising concern about the marketing of unproven stem cell therapies to treat people infected with Coronavirus disease (COVID-19).While stem cell research shows promise for numerous diseases and conditions, there currently are no approved stem cell-based approaches for the prevention and treatment of COVID-19 infection.Despite the unmet need at this challenging time, we need to continue to insist that new therapies are appropriately tested and authorised prior to their use.Clinics claiming that expensive stem cell products can protect people or cause miraculous improvements for those suffering from COVID-19 should be viewed with caution.Legitimate clinical trials are underway to evaluate a range of interventions, from drugs to vaccines and cellular therapies. It remains too early to know if these will work or are safe. Experimental interventions should only be explored under expert medical care and as part of recognised clinical investigation.Anyone trying to find ways to prevent COVID-19 infection or to seek treatment is urged to speak to their doctor and consult the Australian Government website and the World Health Organisation dedicated Coronavirus website. For information, updates and advice about the outbreak in Victoria, please visit the Department of Health and Human Services website.
The Truth
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |